Showing 1461-1470 of 2526 results for "".
- Salus University and National Vision Partner to Educate Optometry Students on Remote Eye Exam Technologyhttps://modernod.com/news/salus-university-and-national-vision-partner-to-educate-optometry-students-on-remote-eye-exam-technology/2477343/Salus University has partnered with National Vision to advance optometric education via a pilot program focused on training students on conducting remote eye exams utilizing high-tech equipment and real-time secure HD video conferencing. The technology enables optometrists to see patients remotel
- FDA Advisory Committee Votes Unanimously to Support the Use of Teprotumumab for the Treatment of Thyroid Eye Disease (TED)https://modernod.com/news/fda-advisory-committee-votes-unanimously-to-support-the-use-of-teprotumumab-for-the-treatment-of-thyroid-eye-disease-ted/2477171/Horizon Therapeutics announced that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the FDA voted unanimously that the potential benefits of teprotumumab, a fully human monoclonal antibody (mAb), outweigh the potential risks for the treatment of Thyroid Eye Disease (TED).
- Eyesight Philanthropist James Chen Awarded Honorary Degree by University of Bathhttps://modernod.com/news/eyesight-philanthropist-james-chen-awarded-honorary-degree-by-university-of-bath/2477169/James Chen, a philanthropist committed to solving global problems associated with vision and eye care, has been awarded an honorary degree from the University of Bath, UK. He received his honorary LLD (Doctor of Laws) degree at the Assembly Rooms, Bath, on Tuesday 10 December (12:15 pm). I
- UK Regulator Unconditionally Clears Roche’s Purchase of Spark Therapeuticshttps://modernod.com/news/uk-regulator-unconditionally-clears-roches-purchase-of-spark-therapeutics/2477170/The UK Competition and Markets Authority (CMA) announced Monday the clearance of Roche’s proposed purchase of Spark Therapeutics after concluding that the deal would not negatively affect competition for haemophilia A treatments. The Swiss drugmaker noted that the offer period under the tra
- Smartphone App Spots Undiagnosed Symptomatic Dry Eye, Helps Identify Risk Factorshttps://modernod.com/news/smartphone-app-spots-undiagnosed-symptomatic-dry-eye-helps-identify-risk-factors/2477144/A smartphone app can identify people with undiagnosed symptomatic dry eye and identify factors linked with the condition, according to a new crowd-sourced study, Reuters reported. “We identified risk factors possibly associated with undiagnosed symptomatic dry eye, including younger
- Nidek Launches the YC-200 and YC-200 S Plus in the United Stateshttps://modernod.com/news/nidek-launches-the-yc-200-and-yc-200-s-plus-in-the-united-states/2477101/Nidek has announced that the FDA has issued 510(k) clearance for the YC-200 Ophthalmic YAG Laser System. The YC-200 includes the S plus model for Selective Laser Trabeculoplasty (SLT). With FDA clearance, the YC-200 and YC-200 S plus are now commercially available in the United States. The
- Extreme Dry Eye Left Fox News’ Shannon Bream Suicidal Until She Found Hope in Treatmenthttps://modernod.com/news/extreme-dry-eye-left-fox-news-shannon-bream-suicidal-until-she-found-hope-in-treatment/2477095/Anchor Shannon Bream struggled with extreme pain and could barely sleep until she found hope in treatment, according to a article in
- Understanding the Eye’s ‘Plumbing’ Could Lead to Future Treatments for Glaucoma, Other Diseaseshttps://modernod.com/news/understanding-the-eyes-plumbing-could-lead-to-future-treatments-for-glaucoma-other-diseases/2477092/Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye. Funded by a $2.3 million 5-year grant from the National Institutes of Health (NIH) National Eye Inst
- Visual Dysfunction: An Underrecognized Symptom of Parkinson’s?https://modernod.com/news/visual-dysfunction-an-underrecognized-symptom-of-parkinsons/2477049/Visual symptoms are a potentially underrecognized and undertreated cause of reduced quality of life in Parkinson disease patients, a new study suggests, as reported in Medscape. By analyzing data from a large population health surv
- GenSight Biologics Reports Evidence of GS010 DNA Transfer to Contralateral Eye of Primates Unilaterally Injected With GS010 Gene Therapyhttps://modernod.com/news/gensight-biologics-reports-evidence-of-gs010-dna-transfer-to-contralateral-eye-of-primates-unilaterally-injected-with-gs010-gene-therapy/2476960/GenSight Biologics reported positive proof of GS010 DNA transfer from one eye to the other eye following unilateral intravitreal injection of primates. In a nonclinical study to investigate the local biodistribution of GS010, tissue samples from the non-injected eye of monkeys that had been unila